Drug manufacturers must verify the identity (ID) of their incoming raw materials prior to release into the production process. For some, meeting this requirement involves extracting and testing samples from a small fraction of their incoming containers; for others it means testing every single package. Regardless, all find thorough and compliant material ID a costly exercise, with costs that span operational, personnel, facility planning, capital equipment, maintenance and consumables. Just how costly can it get? Submitted by Ahura Scientific
Read more...
Most Popular
Please wait...